Contemporary Management of Cardiogenic Shock: A Scientific Statement from the American Heart Association

Circulation

Volumn 136, Issue 16, 2017, Pages e232-e268

  Van Diepen, Sean ^a   Katz, Jason N ^a   Albert, Nancy M ^a   Henry, Timothy D ^a   Jacobs, Alice K ^a   Kapur, Navin K ^a   Kilic, Ahmet ^a   Menon, Venu ^a   Ohman, E Magnus ^a   Sweitzer, Nancy K ^a   Thiele, Holger ^a   Washam, Jeffrey B ^a   Cohen, Mauricio G ^a  

^a NONE

Author keywords

AHA Scientific Statements; delivery of health care; disease management; shock, cardiogenic

Indexed keywords

ACETIC ACID; ANTITHROMBOCYTIC AGENT; HYPERTENSIVE FACTOR; INOTROPIC AGENT; TROPONIN;

ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CENTRAL VENOUS PRESSURE; CLINICAL OUTCOME; CLINICAL PRACTICE; CONTINUOUS RENAL REPLACEMENT THERAPY; CORONARY ARTERY BYPASS GRAFT; ELECTROCARDIOGRAM; FIBRINOLYTIC THERAPY; HEALTH CARE PRACTICE; HEALTH CARE UTILIZATION; HEART TRANSPLANTATION; HUMAN; LABORATORY TEST; MEDICAL CARE; NONHUMAN; PALLIATIVE THERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ARTERY CATHETERIZATION; REVASCULARIZATION; REVIEW; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VASCULAR RESISTANCE; HEALTH CARE COST; HEALTH CARE PLANNING; HEMODYNAMICS; INTEGRATED HEALTH CARE SYSTEM; MEDICAL SOCIETY; ORGANIZATION AND MANAGEMENT; PATIENT SELECTION; PREDICTIVE VALUE; RISK FACTOR; SHOCK, CARDIOGENIC; UNITED STATES;

AMERICAN HEART ASSOCIATION; DELIVERY OF HEALTH CARE, INTEGRATED; HEALTH CARE COSTS; HEMODYNAMICS; HUMANS; PATIENT SELECTION; PHENOTYPE; PREDICTIVE VALUE OF TESTS; REGIONAL HEALTH PLANNING; RISK FACTORS; SHOCK, CARDIOGENIC; TREATMENT OUTCOME; UNITED STATES;

EID: 85031940175     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000525     Document Type: Review

References (328)

1. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Bohm M, Ebelt H, Schneider S, Schuler G, Werdan K; IABPSHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287-1296. doi: 10.1056/NEJMoa1208410.
2. Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008;117:686-697. doi: 10.1161/ CIRCULATIONAHA.106.613596.
3. Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic shock. Ann Intern Med. 1999;131:47-59.
4. Kolte D, Khera S, Aronow WS, Mujib M, Palaniswamy C, Sule S, Jain D, Gotsis W, Ahmed A, Frishman WH, Fonarow GC. Trends in incidence, management, and outcomes of cardiogenic shock complicating STelevation myocardial infarction in the United States. J Am Heart Assoc. 2014;3:e000590. doi: 10.1161/JAHA.113.000590.
5. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009;119:1211-1219. doi: 10.1161/CIRCULATIONAHA.108.814947.
6. Jeger RV, Radovanovic D, Hunziker PR, Pfisterer ME, Stauffer JC, Erne P, Urban P; AMIS Plus Registry Investigators. Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med. 2008;149:618-626.
7. Goldberg RJ, Makam RC, Yarzebski J, McManus DD, Lessard D, Gore JM. Decade-long trends (2001-2011) in the incidence and hospital death rates associated with the in-hospital development of cardiogenic shock after acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2016;9:117-125. doi: 10.1161/CIRCOUTCOMES.115.002359.
8. Aissaoui N, Puymirat E, Tabone X, Charbonnier B, Schiele F, Lefevre T, Durand E, Blanchard D, Simon T, Cambou JP, Danchin N. Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries. Eur Heart J. 2012;33:2535-2543. doi: 10.1093/ eurheartj/ehs264.
9. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH. Early revascularization in acute myocardial infarction complicated by cardiogenic shock: SHOCK Investigators: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999;341:625-634. doi: 10.1056/NEJM199908263410901.
10. Le May MR, Wells GA, So DY, Glover CA, Froeschl M, Maloney J, Dionne R, Marquis JF, O'Brien ER, Dick A, Sherrard HL, Trickett J, Poirier P, Blondeau M, Bernick J, Labinaz M. Reduction in mortality as a result of direct transport from the field to a receiving center for primary percutaneous coronary intervention. J Am Coll Cardiol. 2012;60:1223-1230. doi: 10.1016/j.jacc.2012.07.008.
11. Malta Hansen C, Kragholm K, Pearson DA, Tyson C, Monk L, Myers B, Nelson D, Dupre ME, Fosbol EL, Jollis JG, Strauss B, Anderson ML, McNally B, Granger CB. Association of bystander and first-responder intervention with survival after out-of-hospital cardiac arrest in North Carolina, 2010- 2013. JAMA. 2015;314:255-264. doi: 10.1001/jama.2015.7938.
12. Moore L, Evans D, Hameed SM, Yanchar NL, Stelfox HT, Simons R, Kortbeek J, Bourgeois G, Clement J, Lauzier F, Nathens A, Turgeon AF. Mortality in Canadian trauma systems: a multicenter cohort study. Ann Surg. 2017;265:212-217. doi: 10.1097/SLA.0000000000001614.
13. Beurtheret S, Mordant P, Paoletti X, Marijon E, Celermajer DS, Leger P, Pavie A, Combes A, Leprince P. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J. 2013;34:112-120. doi: 10.1093/ eurheartj/ehs081.
14. Jaroszewski DE, Kleisli T, Staley L, Pierce C, Scott R, Steidley DE, DeValeria P, Arabia FA. A traveling team concept to expedite the transfer and management of unstable patients in cardiopulmonary shock. J Heart Lung Transplant. 2011;30:618-623. doi: 10.1016/j.healun.2010.11.018.
15. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:2129-2200. doi: 10.1093/eurheartj/ehw128.
16. published correction appears in Eur Heart J. 2016;38:ehw383
17. Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol. 1967;20:457-464.
18. Forrester JS, Diamond G, Chatterjee K, Swan HJ. Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts). N Engl J Med. 1976;295:1404-1413. doi: 10.1056/ NEJM197612162952505.
19. Scheidt S, Wilner G, Mueller H, Summers D, Lesch M, Wolff G, Krakauer J, Rubenfire M, Fleming P, Noon G, Oldham N, Killip T, Kantrowitz A. Intra-aortic balloon counterpulsation in cardiogenic shock: report of a cooperative clinical trial. N Engl J Med. 1973;288:979-984. doi: 10.1056/ NEJM197305102881901.
20. Menon V, Hochman JS, Stebbins A, Pfisterer M, Col J, Anderson RD, Hasdai D, Holmes DR, Bates ER, Topol EJ, Califf RM, Ohman EM. Lack of progress in cardiogenic shock: lessons from the GUSTO trials. Eur Heart J. 2000;21:1928-1936. doi: 10.1053/euhj.2000.2240.
21. Goldberg RJ, Gore JM, Alpert JS, Osganian V, de Groot J, Bade J, Chen Z, Frid D, Dalen JE. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med. 1991;325:1117-1122. doi: 10.1056/ NEJM199110173251601.
22. Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, Col J, White HD; SHOCK Investigators. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006;295:2511-2515.
23. Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V, Webb JG, Steingart R, Picard MH, Menegus MA, Boland J, Sanborn T, Buller CE, Modur S, Forman R, Desvigne-Nickens P, Jacobs AK, Slater JN, LeJemtel TH; SHOCK Investigators; Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. One-year survival following early revascularization for cardiogenic shock. JAMA. 2001;285:190-192.
24. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541- 2619. doi: 10.1093/eurheartj/ehu278.
25. Sandhu A, McCoy LA, Negi SI, Hameed I, Atri P, Al'Aref SJ, Curtis J, Mc-Nulty E, Anderson HV, Shroff A, Menegus M, Swaminathan RV, Gurm H, Messenger J, Wang T, Bradley SM. Use of mechanical circulatory support in patients undergoing percutaneous coronary intervention: Insights from the National Cardiovascular Data Registry. Circulation. 2015;132:1243- 1251. doi: 10.1161/CIRCULATIONAHA.114.014451.
26. Thiele H, Ohman EM, Desch S, Eitel I, de Waha S. Management of cardiogenic shock. Eur Heart J. 2015;36:1223-1230. doi: 10.1093/eurheartj/ ehv051.
27. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003;107:2998-3002. doi: 10.1161/01.CIR.0000075927.67673.F2.
28. Thiele H, Allam B, Chatellier G, Schuler G, Lafont A. Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J. 2010;31:1828- 1835. doi: 10.1093/eurheartj/ehq220.
29. den Uil CA, Lagrand WK, van der Ent M, Jewbali LS, Cheng JM, Spronk PE, Simoons ML. Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2010;31:3032-3039. doi: 10.1093/eurheartj/ ehq324.
30. den Uil CA, Maat AP, Lagrand WK, van der Ent M, Jewbali LS, van Thiel RJ, Spronk PE, Simoons ML. Mechanical circulatory support devices improve tissue perfusion in patients with end-stage heart failure or cardiogenic shock. J Heart Lung Transplant. 2009;28:906-911. doi: 10.1016/j. healun.2009.05.010.
31. Prondzinsky R, Unverzagt S, Lemm H, Wegener NA, Schlitt A, Heinroth KM, Dietz S, Buerke U, Kellner P, Loppnow H, Fiedler MG, Thiery J, Werdan K, Buerke M. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. Clin Res Cardiol. 2012;101:375-384. doi: 10.1007/s00392-011-0403-3.
32. Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006;114:774-782. doi: 10.1161/CIRCULATIONAHA. 106.612812.
33. Ndrepepa G, Berger PB, Mehilli J, Seyfarth M, Neumann FJ, Schomig A, Kastrati A. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol. 2008;51:690-697. doi: 10.1016/j.jacc.2007.10.040.
34. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004;292:1555-1562. doi: 10.1001/ jama.292.13.1555.
35. Boyer NH. Cardiogenic shock. N Engl J Med. 1944;230:226-229.
36. Freis ED, Schnaper HW, Johnson RL, Schreiner GE. Hemodynamic alterations in acute myocardial infarction, I: cardiac output, mean arterial pressure, total peripheral resistance, central and total blood volumes, venous pressure and average circulation time. J Clin Invest. 1952;31:131-140.
37. Menon V, White H, LeJemtel T, Webb JG, Sleeper LA, Hochman JS. The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry: Should we emergently revascularize Occluded Coronaries in cardiogenic shock? J Am Coll Cardiol. 2000;36(suppl A):1071-1076.
38. Wood LDH. The pathophysiology of the circulation in critical illness. In: Hall JB, Schmidt GA, Wood LDH, eds. Principles of Critical Care. 3rd ed. New York, NY: McGraw-Hill Medical Publishing, 2005:231-248.
39. Tsagalou EP, Kanakakis J, Anastasiou-Nana MI, Drakos SG, Ntalianis AS, Malliaras K, Lazaris N, Katsaros F, Nanas JN. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance. Acute Card Care. 2009;11:99-106. doi: 10.1080/17482940902807286.
40. Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, LeJemtel TH, Cotter G; SHOCK Investigators. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol. 2004;44:340-348. doi: 10.1016/j. jacc.2004.03.060.
41. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, Naftel DC, Ulisney K, Desvigne-Nickens P, Kirklin JK. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant. 2009;28:535-541. doi: 10.1016/j.healun.2009.02.015.
42. Akiyama K, Suzuki H, Grant P, Bing RJ. Oxidation products of nitric oxide, NO2 and NO3, in plasma after experimental myocardial infarction. J Mol Cell Cardiol. 1997;29:1-9. doi: 10.1006/jmcc.1996.9998.
43. TRIUMPH Investigators; Alexander JH, Reynolds HR, Stebbins AL, Dzavik V, Harrington RA, Van de Werf F, Hochman JS. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA. 2007;297:1657-1666.
44. Wildhirt SM, Dudek RR, Suzuki H, Bing RJ. Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction. Int J Cardiol. 1995;50:253-261.
45. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53:31-47.
46. Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004;94:1543-1553. doi: 10.1161/01. RES.0000130526.20854.fa.
47. van Diepen S, Alemayehu WG, Zheng Y, Theroux P, Newby LK, Mahaffey KW, Granger CB, Armstrong PW. Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction. J Thromb Thrombolysis. 2016;42:376-385. doi: 10.1007/s11239-016-1390-z.
48. van Diepen S, Vavalle JP, Newby LK, Clare R, Pieper KS, Ezekowitz JA, Hochman JS, Mahaffey KW, Armstrong PW, Granger CB. The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction. Crit Care Med. 2013;41:2080-2087. doi: 10.1097/ CCM.0b013e31828a67b2.
49. Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, Hochman JS; SHOCK Investigators. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005;165:1643-1650. doi: 10.1001/archinte.165.14.1643.
50. Lim N, Dubois MJ, De Backer D, Vincent JL. Do all nonsurvivors of cardiogenic shock die with a low cardiac index? Chest. 2003;124:1885-1891.
51. Menon V, Slater JN, White HD, Sleeper LA, Cocke T, Hochman JS. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. Am J Med. 2000;108:374-380.
52. Jacobs AK, Leopold JA, Bates E, Mendes LA, Sleeper LA, White H, Davidoff R, Boland J, Modur S, Forman R, Hochman JS. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. J Am Coll Cardiol. 2003;41:1273-1279.
53. Goldstein JA, Tweddell JS, Barzilai B, Yagi Y, Jaffe AS, Cox JL. Importance of left ventricular function and systolic ventricular interaction to right ven tricular performance during acute right heart ischemia. J Am Coll Cardiol. 1992;19:704-711.
54. Goldstein JA, Barzilai B, Rosamond TL, Eisenberg PR, Jaffe AS. Determinants of hemodynamic compromise with severe right ventricular infarction. Circulation. 1990;82:359-368.
55. Dell'Italia LJ, Starling MR, Crawford MH, Boros BL, Chaudhuri TK, O'Rourke RA. Right ventricular infarction: identification by hemodynamic measurements before and after volume loading and correlation with noninvasive techniques. J Am Coll Cardiol. 1984;4:931-939.
56. Harjola VP, Lassus J, Sionis A, Kober L, Tarvasmaki T, Spinar J, Parissis J, Banaszewski M, Silva-Cardoso J, Carubelli V, Di Somma S, Tolppanen H, Zeymer U, Thiele H, Nieminen MS, Mebazaa A; CardShock Study Investigators; GREAT Network. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015;17:501-509. doi: 10.1002/ ejhf.260.
57. published correction appears in Eur J Heart Fail. 2015;17:984
58. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:e344-e426.
59. published correction appears in Circulation. 2014;130:e433-e434
60. Wayangankar SA, Bangalore S, McCoy LA, Jneid H, Latif F, Karrowni W, Charitakis K, Feldman DN, Dakik HA, Mauri L, Peterson ED, Messenger J, Roe M, Mukherjee D, Klein A. Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the Cath- PCI Registry. JACC Cardiovasc Interv. 2016;9:341-351. doi: 10.1016/j. jcin.2015.10.039.
61. Kutty RS, Jones N, Moorjani N. Mechanical complications of acute myocardial infarction. Cardiol Clin. 2013;31:519-531, vii. doi: 10.1016/j. ccl.2013.07.004.
62. Menon V, Webb JG, Hillis LD, Sleeper LA, Abboud R, Dzavik V, Slater JN, Forman R, Monrad ES, Talley JD, Hochman JS. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry: SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol. 2000;36(suppl A):1110-1116.
63. Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011;57:688-696. doi: 10.1016/j.jacc.2010.08.613.
64. Milo-Cotter O, Cotter-Davison B, Lombardi C, Sun H, Bettari L, Bugatti S, Rund M, Metra M, Kaluski E, Kobrin I, Frey A, Rainisio M, McMurray JJ, Teerlink JR, Cotter-Davison G. Neurohormonal activation in acute heart failure: results from VERITAS. Cardiology. 2011;119:96-105. doi: 10.1159/000330409.
65. Shah M, Ali V, Lamba S, Abraham WT. Pathophysiology and clinical spectrum of acute congestive heart failure. Rev Cardiovasc Med. 2001;2(suppl 2):S2-S6.
66. Hausmann H, Potapov EV, Koster A, Krabatsch T, Stein J, Yeter R, Kukucka M, Sodian R, Kuppe H, Hetzer R. Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score. Circulation. 2002;106(suppl 1):I203-I206.
67. Mohite PN, Sabashnikov A, Patil NP, Saez DG, Zych B, Popov AF, Weymann A, Wahlers T, Marczin N, DeRobertis F, Bahrami T, Amrani M, Simon AR. Short-term ventricular assist device in post-cardiotomy cardiogenic shock: factors influencing survival. J Artif Organs. 2014;17:228-235. doi: 10.1007/s10047-014-0773-1.
68. Torchiana DF, Hirsch G, Buckley MJ, Hahn C, Allyn JW, Akins CW, Drake JF, Newell JB, Austen WG. Intraaortic balloon pumping for cardiac support: trends in practice and outcome, 1968 to 1995. J Thorac Cardiovasc Surg. 1997;113:758-764. doi: 10.1016/S0022-5223(97)70235-6.
69. McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000;342:690-695. doi: 10.1056/NEJM200003093421003.
70. Mody KP, Takayama H, Landes E, Yuzefpolskaya M, Colombo PC, Naka Y, Jorde UP, Uriel N. Acute mechanical circulatory support for fulminant myocarditis complicated by cardiogenic shock. J Cardiovasc Transl Res. 2014;7:156-164. doi: 10.1007/s12265-013-9521-9.
71. Rockman HA, Adamson RM, Dembitsky WP, Bonar JW, Jaski BE. Acute fulminant myocarditis: long-term follow-up after circulatory support with left ventricular assist device. Am Heart J. 1991;121(pt 1):922-926.
72. Chen YS, Yu HY, Huang SC, Chiu KM, Lin TY, Lai LP, Lin FY, Wang SS, Chu SH, Ko WJ. Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: what mechanical support should be considered first? J Heart Lung Transplant. 2005;24:81-87. doi: 10.1016/j.healun.2003.09.038.
73. Mirabel M, Luyt CE, Leprince P, Trouillet JL, Leger P, Pavie A, Chastre J, Combes A. Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support. Crit Care Med. 2011;39:1029-1035. doi: 10.1097/CCM.0b013e31820ead45.
74. Elesber AA, Prasad A, Lennon RJ, Wright RS, Lerman A, Rihal CS. Fouryear recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007;50:448-452. doi: 10.1016/j.jacc.2007.03.050.
75. Sharkey SW, Windenburg DC, Lesser JR, Maron MS, Hauser RG, Lesser JN, Haas TS, Hodges JS, Maron BJ. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol. 2010;55:333-341. doi: 10.1016/j.jacc.2009.08.057.
76. Parodi G, Bellandi B, Del Pace S, Barchielli A, Zampini L, Velluzzi S, Carrabba N, Gensini GF, Antoniucci D; Tuscany Registry of Tako-Tsubo Cardiomyopathy. Natural history of tako-tsubo cardiomyopathy. Chest. 2011;139:887-892. doi: 10.1378/chest.10-1041.
77. Otto CM. Calcific aortic valve disease: new concepts. Semin Thorac Cardiovasc Surg. 2010;22:276-284. doi: 10.1053/j.semtcvs.2011.01.009.
78. Wilson N. Rheumatic heart disease in indigenous populations: New Zealand experience. Heart Lung Circ. 2010;19:282-288. doi: 10.1016/j. hlc.2010.02.021.
79. De Bonis M, Maisano F, La Canna G, Alfieri O. Treatment and management of mitral regurgitation. Nat Rev Cardiol. 2011;9:133-146. doi: 10.1038/nrcardio.2011.169.
80. Mathew V, Misgar RA, Ghosh S, Mukhopadhyay P, Roychowdhury P, Pandit K, Mukhopadhyay S, Chowdhury S. Myxedema coma: a new look into an old crisis. J Thyroid Res. 2011;2011:493462. doi: 10.4061/2011/493462.
81. Ertek S, Cicero AF. Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology. Arch Med Sci. 2013;9:944-952. doi: 10.5114/aoms.2013.38685.
82. Haghikia A, Podewski E, Libhaber E, Labidi S, Fischer D, Roentgen P, Tsikas D, Jordan J, Lichtinghagen R, von Kaisenberg CS, Struman I, Bovy N, Sliwa K, Bauersachs J, Hilfiker-Kleiner D. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol. 2013;108:366. doi: 10.1007/ s00395-013-0366-9.
83. Huffman C, Wagman G, Fudim M, Zolty R, Vittorio T. Reversible cardiomyopathies: a review. Transplant Proc. 2010;42:3673-3678. doi: 10.1016/j. transproceed.2010.08.034.
84. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; the Writing Group on behalf of the Joint ESC/ACFF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Circulation. 2012;126:2020-2035. doi: 10.1161/ CIR.0b013e31826e1058.
85. Lemm H, Prondzinsky R, Geppert A, Russ M, Huber K, Werdan K, Buerke M. BNP and NT-proBNP in patients with acute myocardial infarction complicated by cardiogenic shock: results from the IABP Shock trial. Crit Care. 2010;14(suppl 1):P14. doi: 10.1186/cc8378.
86. Shah NR, Bieniarz MC, Basra SS, Paisley RD, Loyalka P, Gregoric ID, Mann DL, Kar B. Serum biomarkers in severe refractory cardiogenic shock. JACC Heart Fail. 2013;1:200-206. doi: 10.1016/j.jchf.2013.03.002.
87. Attana P, Lazzeri C, Chiostri M, Picariello C, Gensini GF, Valente S. Strong-ion gap approach in patients with cardiogenic shock following ST-elevation myocardial infarction. Acute Card Care. 2013;15:58-62. doi: 10.3109/17482941.2013.776691.
88. Valente S, Lazzeri C, Vecchio S, Giglioli C, Margheri M, Bernardo P, Comeglio M, Chiocchini S, Gensini GF. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol. 2007;114:176-182. doi: 10.1016/j.ijcard.2006.01.024.
89. Lazzeri C, Valente S, Chiostri M, Gensini GF. Clinical significance of lactate in acute cardiac patients. World J Cardiol. 2015;7:483-489. doi: 10.4330/ wjc.v7.i8.483.
90. Fuernau G, Poenisch C, Eitel I, Denks D, de Waha S, Poss J, Heine GH, Desch S, Schuler G, Adams V, Werdan K, Zeymer U, Thiele H. Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. Int J Cardiol. 2015;191:159-166. doi: 10.1016/j.ijcard.2015.04.242.
91. Koreny M, Karth GD, Geppert A, Neunteufl T, Priglinger U, Heinz G, Siostrzonek P. Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction. Am J Med. 2002;112:115-119.
92. Gitlin N, Serio KM. Ischemic hepatitis: widening horizons. Am J Gastroenterol. 1992;87:831-836.
93. Cassidy WM, Reynolds TB. Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury. J Clin Gastroenterol. 1994;19:118-121.
94. Aissaoui N, Puymirat E, Juilliere Y, Jourdain P, Blanchard D, Schiele F, Gueret P, Popovic B, Ferrieres J, Simon T, Danchin N. Fifteen-year trends in the management of cardiogenic shock and associated 1-year mortality in elderly patients with acute myocardial infarction: the FAST-MI programme. Eur J Heart Fail. 2016;18:1144-1152. doi: 10.1002/ejhf.585.
95. Redfors B, Angeras O, Ramunddal T, Dworeck C, Haraldsson I, Ioanes D, Petursson P, Libungan B, Odenstedt J, Stewart J, Lodin E, Wahlin M, Albertsson P, Matejka G, Omerovic E. 17-Year trends in incidence and prognosis of cardiogenic shock in patients with acute myocardial infarction in western Sweden. Int J Cardiol. 2015;185:256-262. doi: 10.1016/j.ijcard.2015.03.106.
96. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS; NRMI Investigators. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005;294:448-454. doi: 10.1001/jama.294.4.448.
97. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
98. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A, Harrell FE. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619-1636.
99. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med. 1981;9:591-597.
100. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957-2963.
101. published correction appears in JAMA. 1994;271:1321
102. Kellner P, Prondzinsky R, Pallmann L, Siegmann S, Unverzagt S, Lemm H, Dietz S, Soukup J, Werdan K, Buerke M. Predictive value of outcome scores in patients suffering from cardiogenic shock complicating AMI: APACHE II, APACHE III, Elebute-Stoner, SOFA, and SAPS II. Med Klin Intensivmed Notfmed. 2013;108:666-674. doi: 10.1007/s00063-013-0234-2.
103. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA; Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med. 2003;163:2345-2353. doi: 10.1001/archinte.163.19.2345.
104. Katz JN, Stebbins AL, Alexander JH, Reynolds HR, Pieper KS, Ruzyllo W, Werdan K, Geppert A, Dzavik V, Van de Werf F, Hochman JS; TRIUMPH Investigators. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Am Heart J. 2009;158:680-687. doi: 10.1016/j. ahj.2009.08.005.
105. Hamon M, Agostini D, Le Page O, Riddell JW, Hamon M. Prognostic impact of right ventricular involvement in patients with acute myocardial infarction: meta-analysis. Crit Care Med. 2008;36:2023-2033. doi: 10.1097/CCM.0b013e31817d213d.
106. Picard MH, Davidoff R, Sleeper LA, Mendes LA, Thompson CR, Dzavik V, Steingart R, Gin K, White HD, Hochman JS; for the SHOCK Trial. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock. Circulation. 2003;107:279-284.
107. Sleeper LA, Reynolds HR, White HD, Webb JG, Dzavik V, Hochman JS. A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry. Am Heart J. 2010;160:443-450. doi: 10.1016/j.ahj.2010.06.024.
108. Sanborn TA, Sleeper LA, Webb JG, French JK, Bergman G, Parikh M, Wong SC, Boland J, Pfisterer M, Slater JN, Sharma S, Hochman JS; SHOCK Investigators. Correlates of one-year survival in patients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial. J Am Coll Cardiol. 2003;42:1373-1379.
109. Korabathina R, Heffernan KS, Paruchuri V, Patel AR, Mudd JO, Prutkin JM, Orr NM, Weintraub A, Kimmelstiel CD, Kapur NK. The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction. Catheter Cardiovasc Interv. 2012;80:593-600. doi: 10.1002/ccd.23309.
110. Schuster A, Faulkner M, Zeymer U, Ouarrak T, Eitel I, Desch S, Hasenfus G, Thiele H. Economic implications of intra-aortic balloon support for myocardial infarction with cardiogenic shock: an analysis from the IABP-SHOCK II-trial. Clin Res Cardiol. 2015;104:566-573. doi: 10.1007/ s00392-015-0819-2.
111. Shah RU, de Lemos JA, Wang TY, Chen AY, Thomas L, Sutton NR, Fang JC, Scirica BM, Henry TD, Granger CB. Post-hospital outcomes of patients with acute myocardial infarction with cardiogenic shock: findings from the NCDR. J Am Coll Cardiol. 2016;67:739-747. doi: 10.1016/j. jacc.2015.11.048.
112. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, de Waha A, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Lauer B, Bohm M, Ebelt H, Schneider S, Werdan K, Schuler G; Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) Trial Investigators. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013;382:1638-1645. doi: 10.1016/S0140- 6736(13)61783-3.
113. Sleeper LA, Ramanathan K, Picard MH, Lejemtel TH, White HD, Dzavik V, Tormey D, Avis NE, Hochman JS; SHOCK Investigators. Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol. 2005;46:266-273. doi: 10.1016/j.jacc.2005.01.061.
114. Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? The empirical relation between surgical volume and mortality. N Engl J Med. 1979;301:1364-1369. doi: 10.1056/NEJM197912203012503.
115. Hannan EL, Wu C, Walford G, King SB 3rd, Holmes DR Jr, Ambrose JA, Sharma S, Katz S, Clark LT, Jones RH. Volume-outcome relationships for percutaneous coronary interventions in the stent era. Circulation. 2005;112:1171-1179. doi: 10.1161/CIRCULATIONAHA.104.528455.
116. Jollis JG, Peterson ED, Delong ER, Mark DB, Collins SR, Muhlbaier LH, Pryor DB. The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and short-term mortality. N Engl J Med. 1994;331:1625-1629.
117. Sollano JA, Gelijns AC, Moskowitz AJ, Heitjan DF, Cullinane S, Saha T, Chen JM, Roohan PJ, Reemtsma K, Shields EP. Volume-outcome relationships in cardiovascular operations: New York State, 1990-1995. J Thorac Cardiovasc Surg. 1999;117:419-428.
118. Wen HC, Tang CH, Lin HC, Tsai CS, Chen CS, Li CY. Association between surgeon and hospital volume in coronary artery bypass graft surgery outcomes: a population-based study. Ann Thorac Surg. 2006;81:835-842. doi: 10.1016/j.athoracsur.2005.09.031.
119. Post PN, Kuijpers M, Ebels T, Zijlstra F. The relation between volume and outcome of coronary interventions: a systematic review and meta-analysis. Eur Heart J. 2010;31:1985-1992. doi: 10.1093/eurheartj/ehq151.
120. Badheka AO, Patel NJ, Grover P, Singh V, Patel N, Arora S, Chothani A, Mehta K, Deshmukh A, Savani GT, Patel A, Panaich SS, Shah N, Rathod A, Brown M, Mohamad T, Tamburrino FV, Kar S, Makkar R, O'Neill WW, De Marchena E, Schreiber T, Grines CL, Rihal CS, Cohen MG. Impact of annual operator and institutional volume on percutaneous coronary intervention outcomes: a 5-year United States experience (2005-2009). Circulation. 2014;130:1392-1406.
121. Srinivas VS, Hailpern SM, Koss E, Monrad ES, Alderman MH. Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty. J Am Coll Cardiol. 2009;53:574-579. doi: 10.1016/j.jacc.2008.09.056.
122. Zahn R, Gottwik M, Hochadel M, Senges J, Zeymer U, Vogt A, Meinertz T, Dietz R, Hauptmann KE, Grube E, Kerber S, Sechtem U; Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Volume-outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Heart. 2008;94:329-335. doi: 10.1136/hrt.2007.118737.
123. Harold JG, Bass TA, Bashore TM, Brindis RG, Brush JE Jr, Burke JA, Dehmer GJ, Deychak YA, Jneid H, Jollis JG, Landzberg JS, Levine GN, McClurken JB, Messenger JC, Moussa ID, Muhlestein JB, Pomerantz RM, Sanborn TA, Sivaram CA, White CJ, Williams ES. ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise the 2007 Clinical Competence Statement on Cardiac Interventional Procedures). Circulation. 2013;128:436-472. doi: 10.1161/ CIR.0b013e318299cd8a.
124. Kahn JM, Goss CH, Heagerty PJ, Kramer AA, O'Brien CR, Rubenfeld GD. Hospital volume and the outcomes of mechanical ventilation. N Engl J Med. 2006;355:41-50. doi: 10.1056/NEJMsa053993.
125. Ross JS, Normand SL, Wang Y, Ko DT, Chen J, Drye EE, Keenan PS, Lichtman JH, Bueno H, Schreiner GC, Krumholz HM. Hospital volume and 30-day mortality for three common medical conditions. N Engl J Med. 2010;362:1110-1118. doi: 10.1056/NEJMsa0907130.
126. Shaefi S, O'Gara B, Kociol RD, Joynt K, Mueller A, Nizamuddin J, Mahmood E, Talmor D, Shahul S. Effect of cardiogenic shock hospital volume on mortality in patients with cardiogenic shock. J Am Heart Assoc. 2015;4:e001462. doi: 10.1161/JAHA.114.001462.
127. Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN, Brass LM, Koroshetz W, Marler JR, Booss J, Zorowitz RD, Croft JB, Magnis E, Mulligan D, Jagoda A, O'Connor R, Cawley CM, Connors JJ, Rose-DeRenzy JA, Emr M, Warren M, Walker MD; Brain Attack Coalition. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke. 2005;36:1597-1616. doi: 10.1161/01.STR.0000170622.07210.b4.
128. Celso B, Tepas J, Langland-Orban B, Pracht E, Papa L, Lottenberg L, Flint L. A systematic review and meta-analysis comparing outcome of severely injured patients treated in trauma centers following the establishment of trauma systems. J Trauma. 2006;60:371-378. doi: 10.1097/01. ta.0000197916.99629.eb.
129. Graham KJ, Strauss CE, Boland LL, Mooney MR, Harris KM, Unger BT, Tretinyak AS, Satterlee PA, Larson DM, Burke MN, Henry TD. Has the time come for a national cardiovascular emergency care system? Circulation. 2012;125:2035-2044. doi: 10.1161/CIRCULATIONAHA.111.084509.
130. Granger CB, Henry TD, Bates WE, Cercek B, Weaver WD, Williams DO. Development of systems of care for ST-elevation myocardial infarction patients: the primary percutaneous coronary intervention (ST-elevation myocardial infarction-receiving) hospital perspective. Circulation. 2007;116:e55-e59. doi: 10.1161/CIRCULATIONAHA.107.184049.
131. Harris KM, Strauss CE, Duval S, Unger BT, Kroshus TJ, Inampudi S, Cohen JD, Kapsner C, Boland LL, Eales F, Rohman E, Orlandi QG, Flavin TF, Kshettry VR, Graham KJ, Hirsch AT, Henry TD. Multidisciplinary standardized care for acute aortic dissection: design and initial outcomes of a regional care model. Circ Cardiovasc Qual Outcomes. 2010;3:424-430. doi: 10.1161/CIRCOUTCOMES.109.920140.
132. Henry TD, Sharkey SW, Burke MN, Chavez IJ, Graham KJ, Henry CR, Lips DL, Madison JD, Menssen KM, Mooney MR, Newell MC, Pedersen WR, Poulose AK, Traverse JH, Unger BT, Wang YL, Larson DM. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation. 2007;116:721-728. doi: 10.1161/CIRCULATIONAHA.107.694141.
133. MacKenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Frey KP, Egleston BL, Salkever DS, Scharfstein DO. A national evaluation of the effect of trauma-center care on mortality. N Engl J Med. 2006;354:366-378. doi: 10.1056/NEJMsa052049.
134. Mooney MR, Unger BT, Boland LL, Burke MN, Kebed KY, Graham KJ, Henry TD, Katsiyiannis WT, Satterlee PA, Sendelbach S, Hodges JS, Parham WM. Therapeutic hypothermia after out-of-hospital cardiac arrest: evaluation of a regional system to increase access to cooling. Circulation. 2011;124:206-214. doi: 10.1161/CIRCULATIONAHA.110.986257.
135. Ganesh A, Lindsay P, Fang J, Kapral MK, Cote R, Joiner I, Hakim AM, Hill MD. Integrated systems of stroke care and reduction in 30-day mortality: a retrospective analysis. Neurology. 2016;86:898-904. doi: 10.1212/ WNL.0000000000002443.
136. Nichol G, Aufderheide TP, Eigel B, Neumar RW, Lurie KG, Bufalino VJ, Callaway CW, Menon V, Bass RR, Abella BS, Sayre M, Dougherty CM, Racht EM, Kleinman ME, O'Connor RE, Reilly JP, Ossmann EW, Peterson E; on behalf of the American Heart Association Emergency Cardiovascular Care Committee; Council on Arteriosclerosis, Thrombosis, and Vascular Biology; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Advocacy Committee; Council on Quality of Care and Outcomes Research. Regional systems of care for out-of-hospital cardiac arrest: a policy statement from the American Heart Association. Circulation. 2010;121:709-729. doi: 10.1161/CIR.0b013e3181cdb7db.
137. published correction appears in Circulation. 2010;122:e439
138. Rab T, Kern KB, Tamis-Holland JE, Henry TD, McDaniel M, Dickert NW, Cigarroa JE, Keadey M, Ramee S; Interventional Council, American College of Cardiology. Cardiac arrest: a treatment algorithm for emergent invasive cardiac procedures in the resuscitated comatose patient. J Am Coll Cardiol. 2015;66:62-73. doi: 10.1016/j.jacc.2015.05.009.
139. Spaite DW, Bobrow BJ, Stolz U, Berg RA, Sanders AB, Kern KB, Chikani V, Humble W, Mullins T, Stapczynski JS, Ewy GA; Arizona Cardiac Receiving Center Consortium. Statewide regionalization of postarrest care for out-of-hospital cardiac arrest: association with survival and neurologic outcome. Ann Emerg Med. 2014;64:496-506.e1. doi: 10.1016/j. annemergmed.2014.05.028.
140. Jacobs AK, Antman EM, Faxon DP, Gregory T, Solis P. Development of systems of care for ST-elevation myocardial infarction patients: executive summary. Circulation. 2007;116:217-230. doi: 10.1161/ CIRCULATIONAHA.107.184043.
141. published correction appears in Circulation. 2007;116:e77
142. Jollis JG, Al-Khalidi HR, Roettig ML, Berger PB, Corbett CC, Dauerman HL, Fordyce CB, Fox K, Garvey JL, Gregory T, Henry TD, Rokos IC, Sherwood MW, Suter RE, Wilson BH, Granger CB; for the Mission: Lifeline STEMI Systems Accelerator Project. Regional systems of care demonstration project: American Heart Association Mission: Lifeline STEMI Systems Accelerator. Circulation. 2016;134:365-374. doi: 10.1161/CIRCULATIONAHA.115.019474.
143. Jollis JG, Granger CB, Henry TD, Antman EM, Berger PB, Moyer PH, Pratt FD, Rokos IC, Acuna AR, Roettig ML, Jacobs AK. Systems of care for ST-segment-elevation myocardial infarction: a report From the American Heart Association's Mission: Lifeline. Circ Cardiovasc Qual Outcomes. 2012;5:423-428. doi: 10.1161/CIRCOUTCOMES.111.964668.
144. Jollis JG, Roettig ML, Aluko AO, Anstrom KJ, Applegate RJ, Babb JD, Berger PB, Bohle DJ, Fletcher SM, Garvey JL, Hathaway WR, Hoekstra JW, Kelly RV, Maddox WT Jr, Shiber JR, Valeri FS, Watling BA, Wilson BH, Granger CB; Reperfusion of Acute Myocardial Infarction in North Carolina Emergency Departments (RACE) Investigators. Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. JAMA. 2007;298:2371-2380. doi: 10.1001/ jama.298.20.joc70124.
145. Helman DN, Morales DL, Edwards NM, Mancini DM, Chen JM, Rose EA, Oz MC. Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. Ann Thorac Surg. 1999;68:1187-1194.
146. Hasin Y, Danchin N, Filippatos GS, Heras M, Janssens U, Leor J, Nahir M, Parkhomenko A, Thygesen K, Tubaro M, Wallentin LC, Zakke I; Working Group on Acute Cardiac Care of the European Society of Cardiology. Recommendations for the structure, organization, and operation of intensive cardiac care units. Eur Heart J. 2005;26:1676-1682. doi: 10.1093/eurheartj/ehi202.
147. Le May M, van Diepen S, Liszkowski M, Schnell G, Tanguay JF, Granger CB, Ainsworth C, Diodati JG, Fam N, Haichin R, Jassal D, Overgaard C, Tymchak W, Tyrrell B, Osborne C, Wong G. From coronary care units to cardiac intensive care units: recommendations for organizational, staffing, and educational transformation. Can J Cardiol. 2016;32:1204- 1213. doi: 10.1016/j.cjca.2015.11.021.
148. Morrow DA, Fang JC, Fintel DJ, Granger CB, Katz JN, Kushner FG, Kuvin JT, Lopez-Sendon J, McAreavey D, Nallamothu B, Page RL 2nd, Parrillo JE, Peterson PN, Winkelman C; on behalf of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Clinical Cardiology, Council on Cardiovascular Nursing, and Council on Quality of Care and Outcomes Research. Evolution of critical care cardiology: transformation of the cardiovascular intensive care unit and the emerging need for new medical staffing and training models: a scientific statement from the American Heart Association. Circulation. 2012;126:1408-1428. doi: 10.1161/ CIR.0b013e31826890b0.
149. Garan AR, Kirtane A, Takayama H. Redesigning care for patients with acute myocardial infarction complicated by cardiogenic shock: the "shock team." JAMA Surg. 2016;151:684-685. doi: 10.1001/ jamasurg.2015.5514.
150. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362-e425. doi: 10.1161/CIR.0b013e3182742cf6.
151. published correction appears in Circulation. 2013;128:e481
152. Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569-619.
153. Katz JN, Turer AT, Becker RC. Cardiology and the critical care crisis: a perspective. J Am Coll Cardiol. 2007;49:1279-1282. doi: 10.1016/j. jacc.2006.11.036.
154. Katz JN, Minder M, Olenchock B, Price S, Goldfarb M, Washam JB, Barnett CF, Newby LK, van Diepen S. The genesis, maturation, and future of critical care cardiology. J Am Coll Cardiol. 2016;68:67-79. doi: 10.1016/j.jacc.2016.04.036.
155. Hill T, Means G, van Diepen S, Paul T, Katz JN. Cardiovascular critical care: a perceived deficiency among U.S. trainees. Crit Care Med. 2015;43:1853-1858. doi: 10.1097/CCM.0000000000001074.
156. Pronovost PJ, Angus DC, Dorman T, Robinson KA, Dremsizov TT, Young TL. Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review. JAMA. 2002;288:2151-2162.
157. Na SJ, Chung CR, Jeon K, Park CM, Suh GY, Ahn JH, Carriere KC, Song YB, Choi JO, Hahn JY, Choi JH, Choi SH, On YK, Gwon HC, Jeon ES, Kim DK, Yang JH. Association between presence of a cardiac intensivist and mortality in an adult cardiac care unit. J Am Coll Cardiol. 2016;68:2637- 2648. doi: 10.1016/j.jacc.2016.09.947.
158. Dehmer GJ, Drozda JP Jr, Brindis RG, Masoudi FA, Rumsfeld JS, Slattery LE, Oetgen WJ. Public reporting of clinical quality data: an update for cardiovascular specialists. J Am Coll Cardiol. 2014;63:1239-1245. doi: 10.1016/j.jacc.2013.11.050.
159. Jacobs AK, Antman EM, Ellrodt G, Faxon DP, Gregory T, Mensah GA, Moyer P, Ornato J, Peterson ED, Sadwin L, Smith SC; American Heart Association's Acute Myocardial Infarction Advisory Working Group. Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention. Circulation. 2006;113:2152-2163.
160. Bangalore S, Gupta N, Guo Y, Lala A, Balsam L, Roswell RO, Reyentovich A, Hochman JS. Outcomes with invasive vs conservative management of cardiogenic shock complicating acute myocardial infarction. Am J Med. 2015;128:601-608. doi: 10.1016/j.amjmed.2014.12.009.
161. Lee L, Erbel R, Brown TM, Laufer N, Meyer J, O'Neill WW. Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival. J Am Coll Cardiol. 1991;17:599-603.
162. Yusuf S, Collins R, Peto R, Furberg C, Stampfer MJ, Goldhaber SZ, Hennekens CH. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J. 1985;6:556-585.
163. Col NF, Gurwitz JH, Alpert JS, Goldberg RJ. Frequency of inclusion of patients with cardiogenic shock in trials of thrombolytic therapy. Am J Cardiol. 1994;73:149-157.
164. Holmes DR Jr, Bates ER, Kleiman NS, Sadowski Z, Horgan JH, Morris DC, Califf RM, Berger PB, Topol EJ. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 1995;26:668-674.
165. Prewitt RM, Gu S, Schick U, Ducas J. Effect of a mechanical vs a pharmacologic increase in aortic pressure on coronary blood flow and thrombolysis induced by IV administration of a thrombolytic agent. Chest. 1997;111:449-453.
166. Ohman EM, Nanas J, Stomel RJ, Leesar MA, Nielsen DW, O'Dea D, Rogers FJ, Harber D, Hudson MP, Fraulo E, Shaw LK, Lee KL; TACTICS Trial. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis. 2005;19:33-39. doi: 10.1007/s11239-005-0938-0.
167. Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, Dens J, Dzavik V, Palmeri ST, Webb JG, Goldberger M, Hochman JS. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol. 2000;36(suppl A):1123-1129.
168. Urban P, Stauffer JC, Bleed D, Khatchatrian N, Amann W, Bertel O, van den Brand M, Danchin N, Kaufmann U, Meier B, Machecourt J, Pfisterer M. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction: the (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur Heart J. 1999;20:1030-1038. doi: 10.1053/euhj.1998.1353.
169. Dzavik V, Sleeper LA, Cocke TP, Moscucci M, Saucedo J, Hosat S, Jiang X, Slater J, LeJemtel T, Hochman JS; SHOCK Investigators. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J. 2003;24:828-837.
170. Jeger RV, Urban P, Harkness SM, Tseng CH, Stauffer JC, Lejemtel TH, Sleeper LA, Pfisterer ME, Hochman JS. Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: a pooled analysis of trials. Acute Card Care. 2011;13:14-20. doi: 10.3109/17482941.2010.538696.
171. Antoniucci D, Valenti R, Migliorini A, Moschi G, Parodi G, Dovellini EV, Bolognese L, Santoro GM. Comparison of impact of emergency percutaneous revascularization on outcome of patients > or =75 to those < 75 years of age with acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol. 2003;91:1458-1461, A6.
172. Kunadian V, Qiu W, Bawamia B, Veerasamy M, Jamieson S, Zaman A. Gender comparisons in cardiogenic shock during ST elevation myocardial infarction treated by primary percutaneous coronary intervention. Am J Cardiol. 2013;112:636-641. doi: 10.1016/j.amjcard.2013.04.038.
173. Lim HS, Farouque O, Andrianopoulos N, Yan BP, Lim CC, Brennan AL, Reid CM, Freeman M, Charter K, Black A, New G, Ajani AE, Duffy SJ, Clark DJ; Melbourne Interventional Group. Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock. JACC Cardiovasc Interv. 2009;2:146-152. doi: 10.1016/j.jcin.2008.11.006.
174. Palmeri ST, Lowe AM, Sleeper LA, Saucedo JF, Desvigne-Nickens P, Hochman JS; SHOCK Investigators. Racial and ethnic differences in the treatment and outcome of cardiogenic shock following acute myocardial infarction. Am J Cardiol. 2005;96:1042-1049. doi: 10.1016/j. amjcard.2005.06.033.
175. Farkouh ME, Ramanathan K, Aymong ED, Webb JG, Harkness SM, Sleeper LA, Hochman JS. An early revascularization strategy is associated with a survival benefit for diabetic patients in cardiogenic shock after acute myocardial infarction. Clin Cardiol. 2006;29:204-210.
176. Jeger RV, Harkness SM, Ramanathan K, Buller CE, Pfisterer ME, Sleeper LA, Hochman JS; SHOCK Investigators. Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry. Eur Heart J. 2006;27:664-670. doi: 10.1093/eurheartj/ ehi729.
177. Zeymer U, Vogt A, Zahn R, Weber MA, Tebbe U, Gottwik M, Bonzel T, Senges J, Neuhaus KL; Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI): results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Eur Heart J. 2004;25:322-328. doi: 10.1016/j.ehj.2003.12.008.
178. Webb JG, Lowe AM, Sanborn TA, White HD, Sleeper LA, Carere RG, Buller CE, Wong SC, Boland J, Dzavik V, Porway M, Pate G, Bergman G, Hochman JS; SHOCK Investigators. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol. 2003;42:1380-1386.
179. Webb JG, Sanborn TA, Sleeper LA, Carere RG, Buller CE, Slater JN, Baran KW, Koller PT, Talley JD, Porway M, Hochman JS; SHOCK Investigators. Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am Heart J. 2001;141:964-970. doi: 10.1067/ mhj.2001.115294.
180. Jaguszewski M, Ghadri JR, Seifert B, Hiestand T, Herrera P, Gaemperli O, Landmesser U, Maier W, Nallamothu BK, Windecker S, Luscher TF, Templin C. Drug-eluting stents vs. bare metal stents in patients with cardiogenic shock: a comparison by propensity score analysis. J Cardiovasc Med (Hagerstown). 2015;16:220-229. doi: 10.2459/ JCM.0000000000000106.
181. Marcolino MS, Simsek C, de Boer SP, van Domburg RT, van Geuns RJ, de Jaegere P, Akkerhuis KM, Daemen J, Serruys PW, Boersma E. Short- and long-term major adverse cardiac events in patients undergoing percutaneous coronary intervention with stenting for acute myocardial infarction complicated by cardiogenic shock. Cardiology. 2012;121:47-55. doi: 10.1159/000336154.
182. Ledwoch J, Fuernau G, Desch S, Eitel I, Jung C, de Waha S, Poss J, Schneider S, Schuler G, Werdan K, Zeymer U, Theile HT. Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock [published online ahead of print February 7, 2017]. Heart. doi: 10.1136/heartjnl-2016-310403. http://heart.bmj.com/content/early/ 2017/02/06/heartjnl-2016-310403.long.
183. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH, O'Gara PT, Kushner FG, Ascheim DD, Brindis RG, Casey DE Jr, Chung MK, de Lemos JA, Diercks DB, Fang JC, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2015 ACC/ AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2016;133:1135-1147. doi: 10.1161/CIR.0000000000000336.
184. published correction appears in Circulation. 2016;133:e442-443
185. Mehta RH, Lopes RD, Ballotta A, Frigiola A, Sketch MH Jr, Bossone E, Bates ER. Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease? Am Heart J. 2010;159:141-147. doi: 10.1016/j.ahj.2009.10.035.
186. Mylotte D, Morice MC, Eltchaninoff H, Garot J, Louvard Y, Lefevre T, Garot P. Primary percutaneous coronary intervention in patients with acute myocardial infarction, resuscitated cardiac arrest, and cardiogenic shock: the role of primary multivessel revascularization. JACC Cardiovasc Interv. 2013;6:115-125. doi: 10.1016/j.jcin.2012.10.006.
187. Bauer T, Zeymer U, Hochadel M, Mollmann H, Weidinger F, Zahn R, Nef HM, Hamm CW, Marco J, Gitt AK. Use and outcomes of multivessel percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the EHS-PCI Registry). Am J Cardiol. 2012;109:941-946. doi: 10.1016/j.amjcard.2011.11.020.
188. Park JS, Cha KS, Lee DS, Shin D, Lee HW, Oh JH, Kim JS, Choi JH, Park YH, Lee HC, Kim JH, Chun KJ, Hong TJ, Jeong MH, Ahn Y, Chae SC, Kim YJ; Korean Acute Myocardial Infarction Registry Investigators. Culprit or multivessel revascularisation in ST-elevation myocardial infarction with cardiogenic shock. Heart. 2015;101:1225-1232. doi: 10.1136/ heartjnl-2014-307220.
189. Hussain F, Philipp RK, Ducas RA, Elliott J, Džavik V, Jassal DS, Tam JW, Roberts D, Garber PJ, Ducas J. The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba Cardiogenic SHOCK Registry Investigators. Catheter Cardiovasc Interv. 2011;78:540-548. doi: 10.1002/ccd.23006.
190. Thiele H, Desch S, Piek JJ, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Noc M, Huber K, Fuernau G, de Waha S, Meyer-Saraei R, Schneider S, Windecker S, Savonitto S, Briggs A, Torremante P, Vrints C, Schuler G, Ceglarek U, Thiery J, Zeymer U; CULPRIT-SHOCK Investigators. Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: design and rationale of CULPRIT-SHOCK trial. Am Heart J. 2016;172:160-169. doi: 10.1016/j.ahj.2015.11.006.
191. Bernat I, Abdelaal E, Plourde G, Bataille Y, Cech J, Pesek J, Koza J, Jirous S, Machaalany J, Dery JP, Costerousse O, Rokyta R, Bertrand OF. Early and late outcomes after primary percutaneous coronary intervention by radial or femoral approach in patients presenting in acute ST-elevation myocardial infarction and cardiogenic shock. Am Heart J. 2013;165:338-343. doi: 10.1016/j.ahj.2013.01.012.
192. Rodriguez-Leor O, Fernandez-Nofrerias E, Carrillo X, Mauri J, Oliete C, Rivas Mdel C, Bayes-Genis A. Transradial percutaneous coronary intervention in cardiogenic shock: a single-center experience. Am Heart J. 2013;165:280-285. doi: 10.1016/j.ahj.2012.08.011.
193. Pancholy SB, Palamaner Subash Shantha G, Romagnoli E, Kedev S, Bernat I, Rao SV, Jolly S, Bertrand OF, Patel TM. Impact of access site choice on outcomes of patients with cardiogenic shock undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Am Heart J. 2015;170:353-361. doi: 10.1016/j.ahj.2015.05.001.
194. Mamas MA, Anderson SG, Ratib K, Routledge H, Neyses L, Fraser DG, Buchan I, de Belder MA, Ludman P, Nolan J; British Cardiovascular Intervention Society; National Institute for Cardiovascular Outcomes Research. Arterial access site utilization in cardiogenic shock in the United Kingdom: is radial access feasible? Am Heart J. 2014;167:900-908.e1. doi: 10.1016/j.ahj.2014.03.007.
195. Seto AH, Roberts JS, Abu-Fadel MS, Czak SJ, Latif F, Jain SP, Raza JA, Mangla A, Panagopoulos G, Patel PM, Kern MJ, Lasic Z. Real-time ultrasound guidance facilitates transradial access: RAUST (Radial Artery access with Ultrasound Trial). JACC Cardiovasc Interv. 2015;8:283-291. doi: 10.1016/j.jcin.2014.05.036.
196. Orban M, Mayer K, Morath T, Bernlochner I, Hadamitzky M, Braun S, Schulz S, Hoppmann P, Hausleiter J, Tiroch K, Mehilli J, Schunkert H, Massberg S, Laugwitz KL, Sibbing D, Kastrati A. Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction: results of the ISAR-SHOCK registry. Thromb Haemost. 2014;112:1190-1197. doi: 10.1160/TH14-06-0489.
197. Orban M, Limbourg T, Neumann FJ, Ferenc M, Olbrich HG, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Poss J, Schneider S, Schuler G, Werdan K, Zeymer U, Thiele H, Hausleiter J. ADP receptor antagonists in patients with acute myocardial infarction complicated by cardiogenic shock: a post hoc IABP-SHOCK II trial subgroup analysis. EuroIntervention. 2016;12:e1395-e1403. doi: 10.4244/ EIJY15M12-04.
198. Siller-Matula JM, Trenk D, Krahenbuhl S, Michelson AD, Delle-Karth G. Clinical implications of drug-drug interactions with P2Y12 receptor inhibitors. J Thromb Haemost. 2014;12:2-13. doi: 10.1111/jth.12445.
199. Antoniucci D, Valenti R, Migliorini A, Moschi G, Trapani M, Dovellini EV, Bolognese L, Santoro GM. Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation. Am J Cardiol. 2002;90:353-357.
200. Chan AW, Chew DP, Bhatt DL, Moliterno DJ, Topol EJ, Ellis SG. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol. 2002;89:132-136.
201. Giri S, Mitchel J, Azar RR, Kiernan FJ, Fram DB, McKay RG, Mennett R, Clive J, Hirst JA. Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol. 2002;89:126-131.
202. Huang R, Sacks J, Thai H, Goldman S, Morrison DA, Barbiere C, Ohm J. Impact of stents and abciximab on survival from cardiogenic shock treated with percutaneous coronary intervention. Catheter Cardiovasc Interv. 2005;65:25-33. doi: 10.1002/ccd.20334.
203. Tousek P, Rokyta R, Tesarova J, Pudil R, Belohlavek J, Stasek J, Rohac F, Widimsky P. Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: the PRAGUE-7 Study: an open randomized multicentre study. Acute Card Care. 2011;13:116-122. doi: 10.3109/17482941.2011.567282.
204. Bonello L, De Labriolle A, Roy P, Steinberg DH, Pinto Slottow TL, Xue Z, Smith K, Torguson R, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R. Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock. Am J Cardiol. 2008;102:287-291. doi: 10.1016/j. amjcard.2008.03.052.
205. Wong SC, Sanborn T, Sleeper LA, Webb JG, Pilchik R, Hart D, Mejnartowicz S, Antonelli TA, Lange R, French JK, Bergman G, LeJemtel T, Hochman JS. Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000;36(suppl A):1077-1083.
206. Vincent JL, Quintairos E Silva A, Couto L Jr, Taccone FS. The value of blood lactate kinetics in critically ill patients: a systematic review. Crit Care. 2016;20:257. doi: 10.1186/s13054-016-1403-5.
207. Richard C, Warszawski J, Anguel N, Deye N, Combes A, Barnoud D, Boulain T, Lefort Y, Fartoukh M, Baud F, Boyer A, Brochard L, Teboul JL; French Pulmonary Artery Catheter Study Group. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2003;290:2713-2720. doi: 10.1001/jama.290.20.2713.
208. Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ, Laporta DP, Viner S, Passerini L, Devitt H, Kirby A, Jacka M; Canadian Critical Care Clinical Trials Group. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003;348:5-14. doi: 10.1056/NEJMoa021108.
209. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wheeler AP, Bernard GR, Thompson BT, Schoenfeld D, Wiedemann HP, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med. 2006;354:2213-2224.
210. Rossello X, Vila M, Rivas-Lasarte M, Ferrero-Gregori A, Sans-Rosello J, Duran-Cambra A, Sionis A. Impact of pulmonary artery catheter use on short- and long-term mortality in patients with cardiogenic shock. Cardiology. 2017;136:61-69. doi: 10.1159/000448110.
211. Hasdai D, Holmes DR Jr, Califf RM, Thompson TD, Hochman JS, Pfisterer M, Topol EJ. Cardiogenic shock complicating acute myocardial infarction: predictors of death. Am Heart J. 1999;138(pt 1):21-31.
212. Petersen JW, Felker GM. Inotropes in the management of acute heart failure. Crit Care Med. 2008;36(suppl):S106-S111. doi: 10.1097/01. CCM.0000296273.72952.39.
213. Werdan K, Rus M, Buerke M, Delle-Karth G, Geppert A, Schondube FA; German Cardiac Society; German Society of Intensive Care and Emergency Medicine; German Society for Thoracic and Cardiovascular Surgery; Austrian Society of Internal and General Intensive Care Medicine; German Interdisciplinary Association of Intensive Care and Emergency Medicine; Austrian Society of Cardiology; German Society of Anaesthesiology and Intensive Care Medicine; German Society of Preventive Medicine and Rehabilitation. Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline. Dtsch Arztebl Int. 2012;109:343-351. doi: 10.3238/arztebl.2012.0343.
214. den Uil CA, Lagrand WK, van der Ent M, Nieman K, Struijs A, Jewbali LS, Constantinescu AA, Spronk PE, Simoons ML. Conventional hemodynamic resuscitation may fail to optimize tissue perfusion: an observational study on the effects of dobutamine, enoximone, and norepinephrine in patients with acute myocardial infarction complicated by cardiogenic shock. PLoS One. 2014;9:e103978. doi: 10.1371/journal.pone.0103978.
215. van Diepen S, Reynolds HR, Stebbins A, Lopes RD, Džavik V, Ruzyllo W, Geppert A, Widimsky P, Ohman EM, Parrillo JE, Dauerman HL, Baran DA, Hochman JS, Alexander JH. Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock. Crit Care Med. 2014;42:281-288. doi: 10.1097/ CCM.0b013e31829f6242.
216. Sim DS, Jeong MH, Cho KH, Ahn Y, Kim YJ, Chae SC, Hong TJ, Seong IW, Chae JK, Kim CJ, Cho MC, Rha SW, Bae JH, Seung KB, Park SJ; Korea Acute Myocardial Infarction Registry (KAMIR) Investigators. Effect of early statin treatment in patients with cardiogenic shock complicating acute myocardial infarction. Korean Circ J. 2013;43:100-109. doi: 10.4070/kcj.2013.43.2.100.
217. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL; SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779-789. doi: 10.1056/NEJMoa0907118.
218. Fuhrmann JT, Schmeisser A, Schulze MR, Wunderlich C, Schoen SP, Rauwolf T, Weinbrenner C, Strasser RH. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Crit Care Med. 2008;36:2257-2266. doi: 10.1097/ CCM.0b013e3181809846.
219. published correction appears in Crit Care Med. 2008;36:2966
220. Pirracchio R, Parenica J, Resche Rigon M, Chevret S, Spinar J, Jarkovsky J, Zannad F, Alla F, Mebazaa A; GREAT Network. The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis. PLoS One. 2013;8:e71659. doi: 10.1371/ journal.pone.0071659.
221. published correction appears in PLoS One. 2013;8
222. Jeon Y, Ryu JH, Lim YJ, Kim CS, Bahk JH, Yoon SZ, Choi JY. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinoneinduced hypotension in off-pump coronary artery bypass surgical patients. Eur J Cardiothorac Surg. 2006;29:952-956. doi: 10.1016/j. ejcts.2006.02.032.
223. Wallace AW, Tunin CM, Shoukas AA. Effects of vasopressin on pulmonary and systemic vascular mechanics. Am J Physiol. 1989;257(pt 2):H1228-H1234.
224. Inglessis I, Shin JT, Lepore JJ, Palacios IF, Zapol WM, Bloch KD, Semigran MJ. Hemodynamic effects of inhaled nitric oxide in right ventricular myocardial infarction and cardiogenic shock. J Am Coll Cardiol. 2004;44:793-798. doi: 10.1016/j.jacc.2004.05.047.
225. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart J. 2014;35:2733-2779. doi: 10.1093/eurheartj/ehu284.
226. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:e783-e831. doi: 10.1161/ CIR.0b013e318223e2bd.
227. van Diepen S, Sligl WI, Washam JB, Gilchrist IC, Arora RC, Katz JN. Prevention of critical care complications in the coronary intensive care unit: protocols, bundles, and insights from intensive care studies. Can J Cardiol. 2017;33:101-109. doi: 10.1016/j.cjca.2016.06.011.
228. Resar R, Pronovost P, Haraden C, Simmonds T, Rainey T, Nolan T. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf. 2005;31:243-248.
229. Pandharipande P, Banerjee A, McGrane S, Ely EW. Liberation and animation for ventilated ICU patients: the ABCDE bundle for the back-end of critical care. Crit Care. 2010;14:157. doi: 10.1186/cc8999.
230. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator- associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
231. Barr J, Fraser GL, Puntillo K, Ely EW, Gelinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM, Coursin DB, Herr DL, Tung A, Robinson BR, Fontaine DK, Ramsay MA, Riker RR, Sessler CN, Pun B, Skrobik Y, Jaeschke R; American College of Critical Care Medicine. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41:263-306. doi: 10.1097/CCM.0b013e3182783b72.
232. Morris AC, Hay AW, Swann DG, Everingham K, McCulloch C, McNulty J, Brooks O, Laurenson IF, Cook B, Walsh TS. Reducing ventilator- associated pneumonia in intensive care: impact of implementing a care bundle. Crit Care Med. 2011;39:2218-2224. doi: 10.1097/ CCM.0b013e3182227d52.
233. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52:e162-e193. doi: 10.1093/cid/cir257.
234. Ling ML, Apisarnthanarak A, Jaggi N, Harrington G, Morikane K, Thu le TA, Ching P, Villanueva V, Zong Z, Jeong JS, Lee CM. APSIC guide for prevention of central line associated bloodstream infections (CLABSI). Antimicrob Resist Infect Contro. 2016;5:16. doi: 10.1186/ s13756-016-0116-5.
235. Marik PE, Vasu T, Hirani A, Pachinburavan M. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis. Crit Care Med. 2010;38:2222-2228. doi: 10.1097/CCM.0b013e3181f17adf.
236. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34:17-60. doi: 10.1007/s00134-007-0934-2.
237. published correction appears in Intensive Care Med. 2008;34:783-785
238. Weir RA, McMurray JJ, Velazquez EJ. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. Am J Cardiol. 2006;97:13F-25F. doi: 10.1016/j.amjcard.2006.03.005.
239. Gray A, Goodacre S, Newby DE, Masson M, Sampson F, Nicholl J; 3CPO Trialists. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med. 2008;359:142-151. doi: 10.1056/NEJMoa0707992.
240. Tobin MJ. Mechanical ventilation. N Engl J Med. 1994;330:1056-1061. doi: 10.1056/NEJM199404143301507.
241. Smith TC, Marini JJ. Impact of PEEP on lung mechanics and work of breathing in severe airflow obstruction. J Appl Physiol (1985). 1988;65:1488-1499.
242. Fessler HE, Brower RG, Wise RA, Permutt S. Mechanism of reduced LV afterload by systolic and diastolic positive pleural pressure. J Appl Physiol (1985). 1988;65:1244-1250.
243. Grace MP, Greenbaum DM. Cardiac performance in response to PEEP in patients with cardiac dysfunction. Crit Care Med. 1982;10:358-360.
244. Peters J. Mechanical ventilation with PEEP: a unique therapy for failing hearts. Intensive Care Med. 1999;25:778-780.
245. Luecke T, Pelosi P. Clinical review: positive end-expiratory pressure and cardiac output. Crit Care. 2005;9:607-621. doi: 10.1186/cc3877.
246. Girardis M, Busani S, Damiani E, Donati A, Rinaldi L, Marudi A, Morelli A, Antonelli M, Singer M. Effect of conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit: the Oxygen-ICU randomized clinical trial. JAMA. 2016;316:1583-1589. doi: 10.1001/jama.2016.11993.
247. Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, Cameron P, Barger B, Ellims AH, Taylor AJ, Meredith IT, Kaye DM; on behalf of the AVOID Investigators. Air versus oxygen in ST-segment-elevation myocardial infarction. Circulation. 2015;131:2143-2150. doi: 10.1161/ CIRCULATIONAHA.114.014494.
248. Sepehrvand N, Ezekowitz JA. Oxygen therapy in patients with acute heart failure: friend or foe? JACC Heart Fail. 2016;4:783-790. doi: 10.1016/j. jchf.2016.03.026.
249. Kilgannon JH, Jones AE, Shapiro NI, Angelos MG, Milcarek B, Hunter K, Parrillo JE, Trzeciak S; Emergency Medicine Shock Research Network (EMShockNet) Investigators. Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA. 2010;303:2165-2171. doi: 10.1001/jama.2010.707.
250. Adler C, Reuter H, Seck C, Hellmich M, Zobel C. Fluid therapy and acute kidney injury in cardiogenic shock after cardiac arrest. Resuscitation. 2013;84:194-199. doi: 10.1016/j.resuscitation.2012.06.013.
251. Lauridsen MD, Gammelager H, Schmidt M, Rasmussen TB, Shaw RE, Botker HE, Sorensen HT, Christiansen CF. Acute kidney injury treated with renal replacement therapy and 5-year mortality after myocardial infarction-related cardiogenic shock: a nationwide population- based cohort study. Crit Care. 2015;19:452. doi: 10.1186/ s13054-015-1170-8.
252. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1-138.
253. Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, Morgan JA, Arabia F, Bauman ME, Buchholz HW, Deng M, Dickstein ML, El-Banayosy A, Elliot T, Goldstein DJ, Grady KL, Jones K, Hryniewicz K, John R, Kaan A, Kusne S, Loebe M, Massicotte MP, Moazami N, Mohacsi P, Mooney M, Nelson T, Pagani F, Perry W, Potapov EV, Eduardo Rame J, Russell SD, Sorensen EN, Sun B, Strueber M, Mangi AA, Petty MG, Rogers J; International Society for Heart and Lung Transplantation. The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32:157-187. doi: 10.1016/j.healun.2012.09.013.
254. Peura JL, Colvin-Adams M, Francis GS, Grady KL, Hoffman TM, Jessup M, John R, Kiernan MS, Mitchell JE, O'Connell JB, Pagani FD, Petty M, Ravichandran P, Rogers JG, Semigran MJ, Toole JM; on behalf of the American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association. Circulation. 2012;126:2648-2667. doi: 10.1161/CIR.0b013e3182769a54.
255. Smedira NG, Moazami N, Golding CM, McCarthy PM, Apperson-Hansen C, Blackstone EH, Cosgrove DM 3rd. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg. 2001;122:92-102. doi: 10.1067/mtc.2001.114351.
256. Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LS, van Domburg RT, Serruys PW. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009;30:2102-2108. doi: 10.1093/eurheartj/ehp292.
257. Alba AC, Rao V, Ivanov J, Ross HJ, Delgado DH. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant. 2009;28:827-833. doi: 10.1016/j. healun.2009.04.033.
258. Lima B, Kale P, Gonzalez-Stawinski GV, Kuiper JJ, Carey S, Hall SA. Effectiveness and safety of the Impella 5.0 as a bridge to cardiac transplantation or durable left ventricular assist device. Am J Cardiol. 2016;117:1622-1628. doi: 10.1016/j.amjcard.2016.02.038.
259. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Baldwin JT, Young JB. The Fourth INTERMACS Annual Report: 4, 000 implants and counting. J Heart Lung Transplant. 2012;31:117-126. doi: 10.1016/j.healun.2011.12.001.
260. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Baldwin JT, Timothy Baldwin J, Young JB. Fifth INTERMACS annual report: risk factor analysis from more than 6, 000 mechanical circulatory support patients. J Heart Lung Transplant. 2013;32:141-156. doi: 10.1016/j.healun.2012.12.004.
261. published correction appears in J Heart Lung Transplant. 2015;34:1345
262. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB. Second INTERMACS annual report: more than 1, 000 primary left ventricular assist device implants. J Heart Lung Transplant. 2010;29:1-10. doi: 10.1016/j.healun.2009.10.009.
263. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Miller MA, Baldwin JT, Young JB. Sixth INTERMACS annual report: A 10, 000-patient database [published correction appears in J Heart Lung Transplant. 2015;34:1356]. J Heart Lung Transplant. 2014;33:555-564.
264. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Myers SL, Miller MA, Baldwin JT, Young JB. Seventh INTERMACS annual report: 15, 000 patients and counting. J Heart Lung Transplant. 2015;34:1495-1504.
265. Prondzinsky R, Unverzagt S, Russ M, Lemm H, Swyter M, Wegener N, Buerke U, Raaz U, Ebelt H, Schlitt A, Heinroth K, Haerting J, Werdan K, Buerke M. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock. 2012;37:378-384. doi: 10.1097/SHK.0b013e31824a67af.
266. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S, Baumgartner H, Gaemperli O, Achenbach S, Agewall S, Badimon L, Baigent C, Bueno H, Bugiardini R, Carerj S, Casselman F, Cuisset T, Erol C, Fitzsimons D, Halle M, Hamm C, Hildick-Smith D, Huber K, Iliodromitis E, James S, Lewis BS, Lip GY, Piepoli MF, Richter D, Rosemann T, Sechtem U, Steg PG, Vrints C, Luis Zamorano J; Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267-315. doi: 10.1093/eurheartj/ehv320.
267. Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJS, Vis MM, Wykrzykowska JJ, Koch KT, Baan J, de Winter RJ, Piek JJ, Lagrand WK, de Mol BA, Tijssen JG, Henriques JP. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017;69:278-287. doi: 10.1016/j.jacc.2016.10.022.
268. O'Neill WW, Schreiber T, Wohns DH, Rihal C, Naidu SS, Civitello AB, Dixon SR, Massaro JM, Maini B, Ohman EM. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol. 2014;27:1-11. doi: 10.1111/joic.12080.
269. Kawashima D, Gojo S, Nishimura T, Itoda Y, Kitahori K, Motomura N, Morota T, Murakami A, Takamoto S, Kyo S, Ono M. Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J. 2011;57:169-176. doi: 10.1097/MAT.0b013e31820e121c.
270. Koeckert MS, Jorde UP, Naka Y, Moses JW, Takayama H. Impella LP 2.5 for left ventricular unloading during venoarterial extracorporeal membrane oxygenation support. J Card Surg. 2011;26:666-668. doi: 10.1111/j.1540-8191.2011.01338.x.
271. Paden ML, Conrad SA, Rycus PT, Thiagarajan RR; ELSO Registry. Extracorporeal Life Support Organization Registry report 2012. ASAIO J. 2013;59:202-210. doi: 10.1097/MAT.0b013e3182904a52.
272. Extracorporeal Life Support Organization. ECLS Registry report. https://www.elso.org/Registry/Statistics/InternationalSummary.aspx. Accessed August 20, 2016.
273. Elsharkawy HA, Li L, Esa WA, Sessler DI, Bashour CA. Outcome in patients who require venoarterial extracorporeal membrane oxygenation support after cardiac surgery. J Cardiothorac Vasc Anesth. 2010;24:946-951. doi: 10.1053/j.jvca.2010.03.020.
274. Lorusso R, Centofanti P, Gelsomino S, Barili F, Di Mauro M, Orlando P, Botta L, Milazzo F, Actis Dato G, Casabona R, Casali G, Musumeci F, De Bonis M, Zangrillo A, Alfieri O, Pellegrini C, Mazzola S, Coletti G, Vizzardi E, Bianco R, Gerosa G, Massetti M, Caldaroni F, Pilato E, Pacini D, Di Bartolomeo R, Marinelli G, Sponga S, Livi U, Mauro R, Mariscalco G, Beghi C, Miceli A, Glauber M, Pappalardo F, Russo CF; GIROC Investigators. Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience. Ann Thorac Surg. 2016;101:919-926. doi: 10.1016/j. athoracsur.2015.08.014.
275. Anderson MB, Goldstein J, Milano C, Morris LD, Kormos RL, Bhama J, Kapur NK, Bansal A, Garcia J, Baker JN, Silvestry S, Holman WL, Douglas PS, O'Neill W. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant. 2015;34:1549-1560. doi: 10.1016/j.healun.2015.08.018.
276. Atiemo AD, Conte JV, Heldman AW. Resuscitation and recovery from acute right ventricular failure using a percutaneous right ventricular assist device. Catheter Cardiovasc Interv. 2006;68:78-82. doi: 10.1002/ ccd.20691.
277. Slaughter MS, Tsui SS, El-Banayosy A, Sun BC, Kormos RL, Mueller DK, Massey HT, Icenogle TB, Farrar DJ, Hill JD; IVAD Study Group. Results of a multicenter clinical trial with the Thoratec implantable ventricular assist device. J Thorac Cardiovasc Surg. 2007;133:1573-1580. doi: 10.1016/j.jtcvs.2006.11.050.
278. published correction appears in J Thorac Cardiovasc Surg. 2007;134:A34
279. John R, Long JW, Massey HT, Griffith BP, Sun BC, Tector AJ, Frazier OH, Joyce LD. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141:932-939. doi: 10.1016/j. jtcvs.2010.03.046.
280. Zeriouh M, Mohite P, Raj B, Sabashnikov A, Fatullayev J, Saez DG, Zych B, Ghodsizad A, Rahmanian P, Choi YH, Wahlers T, Simon AR, Popov AF, Koch A. Short-term ventricular assist device as a bridge to decision in cardiogenic shock: is it a justified strategy? Int J Artif Organs. 2016;39:114-120. doi: 10.5301/ijao.5000488.
281. Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Radovancevic B, Poirier VL, Dasse KA; HeartMate LVAS Investigators; Left Ventricular Assist System. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001;122:1186-1195. doi: 10.1067/ mtc.2001.118274.
282. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443. doi: 10.1056/NEJMoa012175.
283. Chou J, Bermudez C, Kormos R, Teuteberg J. Permanent continuous flow left ventricular assist devices use after acute stabilization for cardiogenic shock in acute myocardial infarction. ASAIO J. 2017;63:e13-e17. doi: 10.1097/MAT.0000000000000398
284. Kirklin JK, Naftel DC, Stevenson LW, Kormos RL, Pagani FD, Miller MA, Ulisney K, Young JB. INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant. 2008;27:1065- 1072. doi: 10.1016/j.healun.2008.07.021.
285. Lund LH, Edwards LB, Kucheryavaya AY, Dipchand AI, Benden C, Christie JD, Dobbels F, Kirk R, Rahmel AO, Yusen RD, Stehlik J; International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report-2013: focus theme: age. J Heart Lung Transplant. 2013;32:951-964. doi: 10.1016/j.healun.2013.08.006.
286. Stegman BM, Newby LK, Hochman JS, Ohman EM. Post-myocardial infarction cardiogenic shock is a systemic illness in need of systemic treatment: is therapeutic hypothermia one possibility? J Am Coll Cardiol. 2012;59:644-647. doi: 10.1016/j.jacc.2011.11.010.
287. Zobel C, Adler C, Kranz A, Seck C, Pfister R, Hellmich M, Kochanek M, Reuter H. Mild therapeutic hypothermia in cardiogenic shock syndrome. Crit Care Med. 2012;40:1715-1723. doi: 10.1097/ CCM.0b013e318246b820.
288. Unverzagt S, Wachsmuth L, Hirsch K, Thiele H, Buerke M, Haerting J, Werdan K, Prondzinsky R. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev. 2014:CD009669. doi: 10.1002/14651858.CD009669.pub2
289. Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF Jr, Dorobantu MI, Grinfeld LR, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin TM, Metra M; RELAXin in Acute Heart Failure (RELAX-AHF) Investigators. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet. 2013;381:29-39. doi: 10.1016/S0140-6736(12)61855-8.
290. Braun LT, Grady KL, Kutner JS, Adler E, Berlinger N, Boss R, Butler J, Enguidanos S, Friebert S, Gardner TJ, Higgins P, Holloway R, Konig M, Meier D, Morrissey MB, Quest TE, Wiegand DL, Coombs-Lee B, Fitchett G, Gupta C, Roach WH Jr; on behalf of the American Heart Association Advocacy Coordinating Committee. Palliative care and cardiovascular disease and stroke: a policy statement from the American Heart Association/American Stroke Association. Circulation. 2016;134:e198- e225. doi: 10.1161/CIR.0000000000000438.
291. Meyers DE, Goodlin SJ. End-of-life decisions and palliative care in advanced heart failure. Can J Cardiol. 2016;32:1148-1156. doi: 10.1016/j. cjca.2016.04.015.
292. Aslakson RA, Curtis JR, Nelson JE. The changing role of palliative care in the ICU. Crit Care Med. 2014;42:2418-2428. doi: 10.1097/ CCM.0000000000000573.
293. Greener DT, Quill T, Amir O, Szydlowski J, Gramling RE. Palliative care referral among patients hospitalized with advanced heart failure. J Palliat Med. 2014;17:1115-1120. doi: 10.1089/jpm.2013.0658.
294. Albert N, Trochelman K, Li J, Lin S. Signs and symptoms of heart failure: are you asking the right questions? Am J Crit Care. 2010;19:443-452. doi: 10.4037/ajcc2009314.
295. Gavazzi A, De Maria R, Manzoli L, Bocconcelli P, Di Leonardo A, Frigerio M, Gasparini S, Humar F, Perna G, Pozzi R, Svanoni F, Ugolini M, Deales A. Palliative needs for heart failure or chronic obstructive pulmonary disease: results of a multicenter observational registry. Int J Cardiol. 2015;184:552-558. doi: 10.1016/j.ijcard.2015.03.056.
296. Mandawat A, Heidenreich PA, Mandawat A, Bhatt DL. Trends in palliative care use in veterans with severe heart failure using a large national cohort. JAMA Cardiol. 2016;1:617-619. doi: 10.1001/jamacardio.2016.1687.
297. Erne P, Radovanovic D, Seifert B, Bertel O, Urban P; AMIS Plus Investigators. Outcome of patients admitted with acute coronary syndrome on palliative treatment: insights from the nationwide AMIS Plus Registry 1997-2014. BMJ Open. 2015;5:e006218. doi: 10.1136/ bmjopen-2014-006218.
298. Kavalieratos D, Mitchell EM, Carey TS, Dev S, Biddle AK, Reeve BB, Abernethy AP, Weinberger M. "Not the 'grim reaper service'": an assessment of provider knowledge, attitudes, and perceptions regarding palliative care referral barriers in heart failure. J Am Heart Assoc. 2014;3:e000544. doi: 10.1161/JAHA.113.000544.
299. Hjelmfors L, Stromberg A, Friedrichsen M, Martensson J, Jaarsma T. Communicating prognosis and end-of-life care to heart failure patients: a survey of heart failure nurses' perspectives. Eur J Cardiovasc Nurs. 2014;13:152-161. doi: 10.1177/1474515114521746.
300. Boyd KJ, Worth A, Kendall M, Pratt R, Hockley J, Denvir M, Murray SA. Making sure services deliver for people with advanced heart failure: a longitudinal qualitative study of patients, family carers, and health professionals. Palliat Med. 2009;23:767-776. doi: 10.1177/0269216309346541.
301. Cheang MH, Rose G, Cheung CC, Thomas M. Current challenges in palliative care provision for heart failure in the UK: a survey on the perspectives of palliative care professionals. Open Heart. 2015;2:e000188. doi: 10.1136/openhrt-2014-000188.
302. Metzger M, Norton SA, Quinn JR, Gramling R. "That Don't Work for Me": Patients' and Family Members' Perspectives on Palliative Care and Hospice in Late-Stage Heart Failure. J Hosp Palliat Nurs. 2013;15:177-182. doi: 10.1097/NJH.0b013e3182798390.
303. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJV, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240-e327.
304. Thorvaldsen T, Benson L, Stahlberg M, Dahlstrom U, Edner M, Lund LH. Triage of patients with moderate to severe heart failure: who should be referred to a heart failure center? J Am Coll Cardiol. 2014;63:661-671. doi: 10.1016/j.jacc.2013.10.017.
305. Hopp FP, Zalenski RJ, Waselewsky D, Burn J, Camp J, Welch RD, Levy P. Results of a hospital-based palliative care intervention for patients with an acute exacerbation of chronic heart failure. J Card Fail. 2016;22:1033- 1036. doi: 10.1016/j.cardfail.2016.04.004.
306. Sidebottom AC, Jorgenson A, Richards H, Kirven J, Sillah A. Inpatient palliative care for patients with acute heart failure: outcomes from a randomized trial. J Palliat Med. 2015;18:134-142. doi: 10.1089/ jpm.2014.0192.
307. Denvir MA, Cudmore S, Highet G, Robertson S, Donald L, Stephen J, Haga K, Hogg K, Weir CJ, Murray SA, Boyd K. Phase 2 randomised controlled trial and feasibility study of future care planning in patients with advanced heart disease. Sci Rep. 2016;6:24619. doi: 10.1038/ srep24619.
308. Peterson PN, Rumsfeld JS, Liang L, Albert NM, Hernandez AF, Peterson ED, Fonarow GC, Masoudi FA; on behalf of the American Heart Association Get With The Guidelines-Heart Failure Program. A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association Get With The Guidelines Program. Circ Cardiovasc Qual Outcomes. 2010;3:25-32.
309. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ; ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572-580. doi: 10.1001/jama.293.5.572.
310. Mebazaa A, Yilmaz MB, Levy P, Ponikowski P, Peacock WF, Laribi S, Ristic AD, Lambrinou E, Masip J, Riley JP, McDonagh T, Mueller C, deFilippi C, Harjola VP, Thiele H, Piepoli MF, Metra M, Maggioni A, McMurray J, Dickstein K, Damman K, Seferovic PM, Ruschitzka F, Leite-Moreira AF, Bellou A, Anker SD, Filippatos G. Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. Eur J Heart Fail. 2015;17:544-558. doi: 10.1002/ ejhf.289.
311. Coles AH, Fisher K, Darling C, Yarzebski J, McManus DD, Gore JM, Lessard D, Goldberg RJ. Long-term survival for patients with acute decompensated heart failure according to ejection fraction findings. Am J Cardiol. 2014;114:862-868. doi: 10.1016/j.amjcard.2014.06.017.
312. Gargani L, Pang PS, Frassi F, Miglioranza MH, Dini FL, Landi P, Picano E. Persistent pulmonary congestion before discharge predicts rehospitalization in heart failure: a lung ultrasound study. Cardiovasc Ultrasound. 2015;13:40. doi: 10.1186/s12947-015-0033-4.
313. Omar HR, Guglin M. Rise in BNP despite appropriate acute decompensated heart failure treatment: Patient characteristics and outcomes. Herz. 2017;42:411-417. doi: 10.1007/s00059-016-4478-5.
314. Levy WC, Mozaffarian D, Linker DT, Farrar DJ, Miller LW; REMATCH Investigators. Can the Seattle Heart Failure Model be used to riskstratify heart failure patients for potential left ventricular assist device therapy? J Heart Lung Transplant. 2009;28:231-236. doi: 10.1016/j. healun.2008.12.015.
315. Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JG, Carson PE, Maggioni AP, Mann DL, Pitt B, Poole-Wilson PA, Levy WC. Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation. 2007;116:392-398. doi: 10.1161/ CIRCULATIONAHA.106.687103.
316. Russell SD, Miller LW, Pagani FD. Advanced heart failure: a call to action. Congest Heart Fail. 2008;14:316-321. doi: 10.1111/j.1751- 7133.2008.00022.x.
317. Shah AB, Udeoji DU, Baraghoush A, Bharadwaj P, Yennurajalingam S, Schwarz ER. An evaluation of the prevalence and severity of pain and other symptoms in acute decompensated heart failure. J Palliat Med. 2013;16:87-90. doi: 10.1089/jpm.2012.0248.
318. Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, Truman B, Speroff T, Gautam S, Margolin R, Hart RP, Dittus R. Delirium in mechanically ventilated patients: validity and reliability of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). JAMA. 2001;286:2703-2710.
319. Gelinas C, Fillion L, Puntillo KA. Item selection and content validity of the Critical-Care Pain Observation Tool for non-verbal adults. J Adv Nurs. 2009;65:203-216. doi: 10.1111/j.1365-2648.2008.04847.x.
320. Honda S, Nagai T, Sugano Y, Okada A, Asaumi Y, Aiba T, Noguchi T, Kusano K, Ogawa H, Yasuda S, Anzai T; NaDEF Investigators. Prevalence, determinants, and prognostic significance of delirium in patients with acute heart failure. Int J Cardiol. 2016;222:521-527. doi: 10.1016/j. ijcard.2016.07.236.
321. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-699. doi: 10.1111/j.1532-5415.2005.53221.x.
322. O'Callaghan A, Laking G, Frey R, Robinson J, Gott M. Can we predict which hospitalised patients are in their last year of life? A prospective cross-sectional study of the Gold Standards Framework Prognostic Indicator Guidance as a screening tool in the acute hospital setting. Palliat Med. 2014;28:1046-1052. doi: 10.1177/0269216314536089.
323. Persichini R, Gay F, Schmidt M, Mayaux J, Demoule A, Morelot-Panzini C, Similowski T. Diagnostic accuracy of respiratory distress observation scales as surrogates of dyspnea self-report in intensive care unit patients. Anesthesiology. 2015;123:830-837. doi: 10.1097/ALN. 0000000000000805.
324. Swetz KM, Freeman MR, AbouEzzeddine OF, Carter KA, Boilson BA, Ottenberg AL, Park SJ, Mueller PS. Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. Mayo Clin Proc. 2011;86:493-500. doi: 10.4065/ mcp.2010.0747.
325. Downar J, Delaney JW, Hawryluck L, Kenny L. Guidelines for the withdrawal of life-sustaining measures. Intensive Care Med. 2016;42:1003- 1017. doi: 10.1007/s00134-016-4330-7.
326. McCabe JM, Waldo SW, Kennedy KF, Yeh RW. Treatment and outcomes of acute myocardial infarction complicated by shock after public reporting policy changes in New York. JAMA Cardiol. 2016;1:648-654. doi: 10.1001/jamacardio.2016.1806.
327. Bangalore S, Guo Y, Xu J, Blecker S, Gupta N, Feit F, Hochman JS. Rates of invasive management of cardiogenic shock in New York before and after exclusion from public reporting. JAMA Cardiol. 2016;1:640-647. doi: 10.1001/jamacardio.2016.0785.
328. van Diepen S, Cook DJ, Jacka M, Granger CB. Critical care cardiology research: a call to action. Circ Cardiovasc Qual Outcomes. 2013;6:237-242. doi: 10.1161/CIRCOUTCOMES.111.969501.